Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7965 USD | -0.31% | -1.55% | -43.51% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.51% | 38.55M | |
+72.65% | 12.28B | |
-19.41% | 7.81B | |
+14.98% | 7.19B | |
-5.13% | 5.23B | |
+5.78% | 4.94B | |
+17.02% | 4.24B | |
-25.36% | 3.97B | |
-40.56% | 2.24B | |
-3.47% | 1.92B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple Contraction;' Buy Rating Kept